Compound Haploinsufficiencies of Ebf1 and Runx1 Genes Impede B Cell Lineage Progression

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2010 Apr 14

PMID 20385820

Citations 31

Authors

Kara Lukin

Scott Fields

Desiree Lopez

Marie Cherrier

Kristina Ternyak

Julita Ramirez

Ann J Feeney

James Hagman

Affiliations

Soon will be listed here.

Abstract

Early B cell factor (EBF)1 is essential for B lineage specification. Previously, we demonstrated the synergistic activation of Cd79a (mb-1) genes by EBF1 and its functional partner, RUNX1. Here, we identified consequences of Ebf1 haploinsufficiency together with haploinsufficiency of Runx1 genes in mice. Although numbers of "committed" pro-B cells were maintained in Ebf1(+/-)Runx1(+/-) (ER(het)) mice, activation of B cell-specific gene transcription was depressed in these cells. Expression of genes encoding Aiolos, kappa0 sterile transcripts, CD2 and CD25 were reduced and delayed in ER(het) pro-B cells, whereas surface expression of BP-1 was increased on late pro-B cells in ER(het) mice. Late pre-B and immature and mature B cells were decreased in the bone marrow of Ebf1(+/-) (E(het)) mice and were nearly absent in ER(het) mice. Although we did not observe significant effects of haploinsuficiencies on IgH or Igkappa rearrangements, a relative lack of Iglambda rearrangements was detected in E(het) and ER(het) pre-B cells. Together, these observations suggest that B cell lineage progression is impaired at multiple stages in the bone marrow of E(het) and ER(het) mice. Furthermore, enforced expression of EBF1 and RUNX1 in terminally differentiated plasmacytoma cells activated multiple early B cell-specific genes synergistically. Collectively, these studies illuminate the effects of reduced Ebf1 dosage and the compounding effects of reduced Runx1 dosage. Our data confirm and extend the importance of EBF1 in regulating target genes and Ig gene rearrangements necessary for B cell lineage specification, developmental progression, and homeostasis.

Citing Articles

Early B-Cell Factor 1: An Archetype for a Lineage-Restricted Transcription Factor Linking Development to Disease.

Sigvardsson M Adv Exp Med Biol. 2024; 1459:143-156.

PMID: 39017843 DOI: 10.1007/978-3-031-62731-6_7.

Transcription factor networks link B-lymphocyte development and malignant transformation in leukemia.

Sigvardsson M Genes Dev. 2023; 37(15-16):703-723.

PMID: 37673459 PMC: 10546977. DOI: 10.1101/gad.349879.122.

Logic and lineage impacts on functional transcription factor deployment for T-cell fate commitment.

Rothenberg E Biophys J. 2021; 120(19):4162-4181.

PMID: 33838137 PMC: 8516641. DOI: 10.1016/j.bpj.2021.04.002.

Loss of function results in B cell immunodeficiency but not T cell in adult zebrafish.

Chi Y, Huang Z, Chen Q, Xiong X, Chen K, Xu J Open Biol. 2018; 8(7).

PMID: 30045885 PMC: 6070721. DOI: 10.1098/rsob.180043.

Molecular Regulation of Differentiation in Early B-Lymphocyte Development.

Sigvardsson M Int J Mol Sci. 2018; 19(7).

PMID: 29966360 PMC: 6073616. DOI: 10.3390/ijms19071928.

References

Thal M, Carvalho T, He T, Kim H, Gao H, Hagman J . Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage. Proc Natl Acad Sci U S A. 2009; 106(2):552-7. PMC: 2626741. DOI: 10.1073/pnas.0802550106. View

Blyth K, Slater N, Hanlon L, Bell M, Mackay N, Stewart M . Runx1 promotes B-cell survival and lymphoma development. Blood Cells Mol Dis. 2009; 43(1):12-9. DOI: 10.1016/j.bcmd.2009.01.013. View

Matheny C, Speck M, Cushing P, Zhou Y, Corpora T, Regan M . Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles. EMBO J. 2007; 26(4):1163-75. PMC: 1852839. DOI: 10.1038/sj.emboj.7601568. View

Kikuchi K, Kasai H, Watanabe A, Lai A, Kondo M . IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression. J Immunol. 2008; 181(1):383-92. PMC: 2586338. DOI: 10.4049/jimmunol.181.1.383. View

Ma L, Teruya-Feldstein J, Behrendt N, Chen Z, Noda T, Hino O . Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev. 2005; 19(15):1779-86. PMC: 1182340. DOI: 10.1101/gad.1314405. View

Maier H, Ostraat R, Gao H, Fields S, Shinton S, Medina K . Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol. 2004; 5(10):1069-77. DOI: 10.1038/ni1119. View

Growney J, Shigematsu H, Li Z, Lee B, Adelsperger J, Rowan R . Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood. 2005; 106(2):494-504. PMC: 1895175. DOI: 10.1182/blood-2004-08-3280. View

Reynaud D, Demarco I, Reddy K, Schjerven H, Bertolino E, Chen Z . Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat Immunol. 2008; 9(8):927-36. PMC: 2699484. DOI: 10.1038/ni.1626. View

Romanow W, Langerak A, Goebel P, van Dongen J, Feeney A, Murre C . E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol Cell. 2000; 5(2):343-53. DOI: 10.1016/s1097-2765(00)80429-3. View

10.

Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe A, Speck N . Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A. 1996; 93(8):3444-9. PMC: 39628. DOI: 10.1073/pnas.93.8.3444. View

11.

Gao H, Lukin K, Ramirez J, Fields S, Lopez D, Hagman J . Opposing effects of SWI/SNF and Mi-2/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5. Proc Natl Acad Sci U S A. 2009; 106(27):11258-63. PMC: 2708696. DOI: 10.1073/pnas.0809485106. View

12.

Lin H, Grosschedl R . Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature. 1995; 376(6537):263-7. DOI: 10.1038/376263a0. View

13.

Okada H, Watanabe T, Niki M, Takano H, Chiba N, Yanai N . AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene. Oncogene. 1998; 17(18):2287-93. DOI: 10.1038/sj.onc.1202151. View

14.

Zhang Z, Cotta C, Stephan R, deGuzman C, Klug C . Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage. EMBO J. 2003; 22(18):4759-69. PMC: 212730. DOI: 10.1093/emboj/cdg464. View

15.

Medina K, Pongubala J, Reddy K, Lancki D, DeKoter R, Kieslinger M . Assembling a gene regulatory network for specification of the B cell fate. Dev Cell. 2004; 7(4):607-17. DOI: 10.1016/j.devcel.2004.08.006. View

16.

North T, de Bruijn M, Stacy T, Talebian L, Lind E, Robin C . Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity. 2002; 16(5):661-72. DOI: 10.1016/s1074-7613(02)00296-0. View

17.

Rolink A, Grawunder U, Winkler T, Karasuyama H, Melchers F . IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int Immunol. 1994; 6(8):1257-64. DOI: 10.1093/intimm/6.8.1257. View

18.

Young F, Ardman B, Shinkai Y, Lansford R, Blackwell T, Mendelsohn M . Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation. Genes Dev. 1994; 8(9):1043-57. DOI: 10.1101/gad.8.9.1043. View

19.

Mullighan C, Goorha S, Radtke I, Miller C, Coustan-Smith E, Dalton J . Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446(7137):758-64. DOI: 10.1038/nature05690. View

20.

Delogu A, Schebesta A, Sun Q, Aschenbrenner K, Perlot T, Busslinger M . Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity. 2006; 24(3):269-81. DOI: 10.1016/j.immuni.2006.01.012. View